Animals react differently to the same stimuli. Individual
behavioral variations may result from a variety of circumstances. Among these influences include hereditary traits,
prenatal dam modification, animal behavior at different
periods of development, especially during the neonatal
and socializing phases, maturational events, and the efficient functioning of the animal’s organ systems (Kaiser
and Sachser, 2005; Weinstock, 2008; Camps et al., 2019).
When discussing the proper organ function in animals, it
is affected by an array of medical complications that can
cause behavioral problems directly or indirectly in our pet
animals, and these complications include those that alter or
eliminate external perception (e.g., blindness), information
perception (e.g., a brain tumor), stress reactions owing to
pain, and those that drastically alter internal processes due
to hormonal or neurological issues (Camps et al., 2019; Haq
et al., 2022). In general, behavioral disorders in animals are
defined as abnormally unpleasant behavior observed by the
animal owner that can be harmful to people or other animals
and that can either directly or indirectly impair the patient’s
well-being. Other ailments in companion animals, such as
aggression, abnormal behaviors associated with pain, and
behavioral issues associated with the vomeronasal organ
and heart failure, must also be taken into consideration during a clinical diagnosis (Camps et al., 2019). For the treatment and management of behavioral disorders in companion
animals, veterinarians combine pharmacological interventions, such as the use of tricyclic antidepressants, selective
serotonin reuptake inhibitors, phenothiazines, benzodiazepines, and occasionally pheromone-based therapies, with
behavioral modification therapies or techniques (Camps
et al., 2019; Haq et al., 2022). A list of drugs that may help
companion animals having behavioral issues is mentioned
in (Table 1). Numerous contributing factors are thought to
have an impact on the utilization of psychopharmaceutical
treatment for aberrant behaviors. They include ideas held
by veterinary teams and dog owners about what constitutes
“normal” and acceptable canine behavior in addition to
worries about cost, safety, and ease of administration. There
is little published research on the use of pharmaceutical
treatment to address unwanted behaviors in companion animals receiving routine veterinary care, despite the general
consensus that greater knowledge on veterinary behavioral
psychopharmacology is needed.